TY  - BOOK
AU  - Amit Senguta
TI  - Biological Drugs: Challenges to Access
SN  - 978-967-0747-26-2
U1  - 615.32 
PY  - 2018///
CY  - Malaysia
PB  - Third World Network
KW  - The Growing Therapeutic and Commercial Importance
KW  - How Biological Drugs Differ from Small Molecule Drugs
KW  - Recombinant Technologies in the Manufacture of Biological Drugs
KW  - Renewed Interest in Biological Medicines
KW  - Why are Biologics and Biosimilars So Expensive
KW  - Biosimilas vs Generics of SMDs
KW  - Technological Barriers to Manufacture of Biosimilars
KW  - Barriers Related to Intellectual Property Rights and Data Exclusivity
KW  - The Evolving Regulatory Landscape for Approval of Biosimilars
KW  - How necessary are Present Requirements to Establish Similarity
ER  -